| Financial Year |
March 31 2023 |
| Monetary Funds |
2,832,623,115.90 |
| Held-for-trading Financial Assets |
26,560,596.08 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,359,500,213.02 |
| Advances to Suppliers |
15,300,027.28 |
| Other Receivables |
7,193,394.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
533,638,124.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
27,014,469.39 |
| Total Current Assets |
4,844,570,989.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,491,695.80 |
| Investment Properties |
-- |
| Fixed Assetes |
848,026,459.53 |
| Under-construction Projects |
413,331,797.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
86,059,727.47 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
33,016,315.74 |
| Deferred Income Tax Assets |
73,407,776.57 |
| Other Non-Current Assets |
25,709,949.64 |
| Sub-Total of Non-Current Assets |
1,515,001,873.74 |
| Total Assets |
6,359,572,862.84 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,300,781.37 |
| Accounts Payable |
876,654,803.95 |
| Accounts Received In Advance |
15,746,213.00 |
| Employee Compensation Payable |
124,393,887.31 |
| Taxes Payable |
33,623,385.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,367,377.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,658,193.66 |
| Other Current Liabilities |
332,323.11 |
| Sub-Total of Current Liabilities |
1,109,630,086.90 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
246,070,982.38 |
| Total Liabilities |
1,355,701,069.28 |
| Paid-In Capital(Or Share Stock) |
705,816,160.00 |
| Capital Surplus |
2,037,997,973.73 |
| Surplus Reserve |
393,708,574.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,985,945,019.08 |
| Minority Stockholder's Interest |
5,763,037.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,998,108,756.26 |
| Owner's Equity（Stockholder's Equity） |
5,003,871,793.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,359,572,862.84 |
